Public company info - Fusen Pharmaceutical Company Limited , 01652.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Fusen Pharmaceutical Company Limited, 01652.HK - Cash Flow 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12
Net Cash Flow from Operating Activities 171,076 41,349 85,722 151,174 186,456 77,502
Net Cash Flow from Return on Investments & Servicing of Finance -9,191 -12,557 -14,841 -34,631 -161,362 -15,361
　Interest Received 2,889 1,966 2,205 20,944 36,015 41,207
　Interest Paid -8,935 -9,168 -15,910 -30,558 -40,101 -42,416
　Dividend Received 0 0 0 0 0 0
　Dividend Paid -3,145 -5,355 -1,136 -25,017 -157,276 -14,152
　Others 0 0 0 0 0 0
Taxes (Paid) / Refunded -17,869 -20,959 -22,904 -17,968 -14,111 -7,698
Net Cash Flow from Investing Activities -71,086 -263,218 -92,928 434,570 291,651 25,978
　Additions to Fixed Assets -58,645 -200,270 -104,353 -9,078 -19,977 -27,837
　Disposal of Fixed Assets 82 30 0 0 1,469 124
　Increase in Investments -76,456 -62,978 0 0 0 0
　Decrease in Investments 63,933 0 0 0 0 0
　Net Cash Flow with Related Parties -330 -31 -4,961 -1,115 60,670 14,022
　Others 330 31 16,386 444,763 249,489 39,669
Net Cash Flow before Financing Activities 72,930 -255,385 -44,951 533,145 302,634 80,421
Net Cash Flow from Financing Activities -104,250 19,969 117,894 -302,795 -90,813 -75,057
　New Loans 210,873 0 190,000 391,600 567,670 864,011
　Loans Repayment -220,000 -100,000 -391,600 -600,678 -719,153 -774,400
　Fixed Income/Debt Instruments 0 0 0 0 0 547,290
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 -339,980
　Equity Financing 0 120,000 324,455 0 0 0
　Net Cash Flow with Related Parties -330 -31 -4,961 -1,115 60,670 14,022
　Others -94,793 0 0 -92,602 0 -386,000
Increase(Decrease) in Cash & Cash Equivalents -31,320 -235,416 72,943 230,350 211,821 5,364
Cash & Cash Equivalents at Beginning of Year 331,044 561,108 474,621 244,390 32,569 27,205
Net Cash Flow due to Change in Exchange Rate/Others -2,686 5,352 13,544 -119 0 0
Cash & Cash Equivalents at End of Year 297,038 331,044 561,108 474,621 244,390 32,569
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved